Nancy J. Hutson, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 7,000 shares at $7.54 ($53K) on 2024-12-13, disclosed to the SEC on 2024-12-16.
Scheduled sale ($53k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |
| BCRX | SELL | 2021-10-19 | $1.6M | — | Filing → |